CDC issues Level 3 warning by December 31?

Traders are pricing in a roughly one-in-three chance that the CDC will issue a Level 3 travel health notice before the end of 2026, a market that serves as a proxy for anticipating significant disease outbreaks or public health emergencies over the next two years.

Current Odds

Platform	Yes	No	Volume	Trade
Polymarket	35.0%	65.0%	$100K	Trade on Polymarket

Market Analysis

The bull case rests on several concerning trends: increasing antimicrobial resistance creating potential superbug outbreaks, ongoing evolution of influenza strains with pandemic potential, and the persistence of mpox and other zoonotic diseases in regions with limited healthcare infrastructure. Bird flu (H5N1) continues circulating in wild bird populations and has shown sporadic mammal-to-mammal transmission, which infectious disease experts identify as a critical warning sign. Climate change is expanding the geographic range of mosquito-borne illnesses like dengue and chikungunya, potentially triggering Level 3 designations for previously unaffected regions. The CDC’s threshold for Level 3 warnings—advising travelers to avoid nonessential travel—is relatively low compared to higher alert levels, requiring only widespread transmission and limited healthcare capacity in affected areas.

The bear case emphasizes that Level 3 warnings remain relatively rare events, typically reserved for significant outbreaks rather than endemic disease patterns. Since COVID-19, global disease surveillance has substantially improved, with genomic sequencing networks and international coordination mechanisms designed to contain outbreaks before they require travel restrictions. The current odds may overestimate risk given that this represents a nearly 30-month window, but historical frequency suggests CDC issues Level 3 warnings sparingly—primarily during major Ebola outbreaks, Zika emergence, and pandemic events. Many potential disease threats have vaccines or treatments in development pipelines, and wealthy nations have invested heavily in pandemic preparedness infrastructure post-2020.

Key catalysts to monitor include the 2025-2026 flu season composition (WHO recommendations come in February and September each year), ongoing mpox case counts from the Democratic Republic of Congo, and any H5N1 human case clusters indicating sustained transmission. The CDC’s Morbidity and Mortality Weekly Report (MMWR) provides early signals on unusual disease patterns. Traders should watch for ProMED alerts on novel pathogens and WHO Emergency Committee meetings, which often precede CDC travel notice escalations by weeks. The market’s December 2026 expiry means seasonal disease patterns will cycle twice, with winter respiratory illness seasons (November-March) and summer arbovirus seasons representing higher-probability windows for outbreak emergence.

Related Markets

• Will JD Vance win the 2028 US Presidential Election? — 18% YES
• Will Pete Buttigieg win the 2028 Democratic presidential nomination? — 4% YES
• Will Amanda Anisimova be the 2026 Women’s Wimbledon Winner? — 5% YES

Frequently Asked Questions

What qualifies as a CDC Level 3 travel health notice versus lower warning levels?

Level 3 indicates “avoid nonessential travel” due to widespread transmission and limited healthcare capacity. This is more severe than Level 2 (enhanced precautions) but below Level 4 (do not travel), and typically applies to entire countries or regions rather than localized outbreaks.

Have there been any CDC Level 3 warnings issued since COVID-19 ended?

The CDC maintained Level 3 warnings for mpox in certain African countries during the 2024 outbreak and has issued Level 3 notices for measles outbreaks in countries with healthcare system strain, though these often receive less public attention than pandemic-level events.

Does this market resolve YES if the Level 3 warning is issued but later downgraded before December 2026?

Yes, the market only requires that the CDC issue a Level 3 warning at any point before the expiry date; the warning does not need to remain active through December 31, 2026 for a YES resolution.